OTHER INFORMATION
−Removed: Copies of the following documents are included as exhibits to this
−Removed: report pursuant to Item 601 of Regulation S-K
−Removed: Therapeutics, Inc.
−Removed: 2021 Equity Incentive Plan
−Removed: Exhibit 10.1 to Current Report on Form 8-K filed on May 20, 2021
−Removed: License Agreement dated as of July 16, 2021, between Arbormentis, LLC and Relmada Therapeutics, Inc.*
−Removed: Filed Herewith
+Added: of the following documents are included as exhibits to this report pursuant to Item 601 of Regulation S-K
Certification
of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
−Removed: Filed herewith
Certification
of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
−Removed: Filed herewith
Certification
1 unchanged sentence
Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
−Removed: Furnished herewith
Certification
1 unchanged sentence
Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
−Removed: Furnished herewith
Inline XBRL Instance Document.
−Removed: Filed herewith
Inline XBRL Taxonomy Extension Schema Document.
−Removed: Filed herewith
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
−Removed: Filed herewith
Inline XBRL Taxonomy Extension Definition Linkbase Document.
−Removed: Filed herewith
Inline XBRL Taxonomy Extension Label Linkbase Document.
−Removed: Filed herewith
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
−Removed: Filed herewith
−Removed: Cover Page Interactive Data File (formatted as Inline XBRL and contained
−Removed: in Exhibit 101).
−Removed: Filed herewith
−Removed: Certain information identified by [***] has been omitted from this exhibit because it is both not material and is the type that the registrant treats as private or confidential.
−Removed: Exhibit attached to this Form 10-Q shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act
−Removed: of 1934 (the “Exchange Act”) or otherwise subject to liability under that section, nor shall it be deemed incorporated by
−Removed: reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific
+Added: Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
+Added: Exhibit attached to this Form 10-Q shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange
+Added: Act of 1934 (the “Exchange Act”) or otherwise subject to liability under that section, nor shall it be deemed incorporated
+Added: by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific
reference in such filing.
−Removed: Pursuant to the requirements of the Securities
−Removed: Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: August 10, 2021
−Removed: /s/ Sergio Traversa
+Added: to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
+Added: the undersigned thereunto duly authorized.
+Added: November 12, 2021
Sergio Traversa
−Removed: Chief Executive Officer
−Removed: (Duly Authorized Officer and
+Added: Executive Officer
+Added: Authorized Officer and
Principal Executive Officer)
−Removed: /s/ Maged Shenouda
Maged Shenouda
−Removed: Chief Financial Officer
−Removed: (Duly Authorized Officer and
+Added: Financial Officer
+Added: Authorized Officer and
Principal Financial and Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.